covid-19 t memory cells and nk cells
Cell therapyexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 4, 2020 (NCT04578210)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, passive
SARS-CoV-2 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04578210 | Phase 1/Phase 2 (Phase 2) | Sep 4, 2020 | Biocruces Bizkaia Health Research Institute, Miguel Hernández University, Universidad Autonoma de Madrid, University of Valencia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biocruces Bizkaia Health Research Institute | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Miguel Hernández University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Universidad Autonoma de Madrid | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2020 |
4 organizations
Page 1 / 1